Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Did the Trial Court Err by Permitting Evidence of Subsequent Angiograms?

0
Posted

Did the Trial Court Err by Permitting Evidence of Subsequent Angiograms?

0

Stalsitz also contended that the trial court should have excluded evidence that he received additional lytic therapy and angioplasty at LVH in 1997, because that evidence was irrelevant. As noted in the trial testimony above, Stalsitz’ subsequent therapy revealed that the original treatment had a patency of more than 5 years. The Superior Court held that evidence of the 1997 lytic therapy and angioplasty on Stalsitz’s leg was relevant because it supported the defendants’ contention that the 1992 angioplasty was an appropriate method of treating the stenosis and did not represent a deviation from the standard of care. POST-APPELLATE HISTORY Last month, Stalsitz filed a Petition for Allocatur20 to the Pennsylvania Supreme Court. If the Supreme Court grants allocatur, the state’s highest court will decide these issues. ANALYSIS The facts and holding in Stalsitz are of interest to endovascular specialists as a snapshot of one case involving endovascular procedures, limb ischemia, and infor

Related Questions

What is your question?

*Sadly, we had to bring back ads too. Hopefully more targeted.